Page last updated: 2024-08-16

trimebutine and scopolamine hydrobromide

trimebutine has been researched along with scopolamine hydrobromide in 3 studies

Research

Studies (3)

Timeframe	Studies, this research(%)	All Research%
pre-1990	1 (33.33)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (33.33)	29.6817
2010's	1 (33.33)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Cantin, LD; Chen, H; Kenna, JG; Noeske, T; Stahl, S; Walker, CL; Warner, DJ	1
Kido, A; Sasaki, D; Yoshida, Y	1
Mearin, F	1

Reviews

1 review(s) available for trimebutine and scopolamine hydrobromide

Article	Year
[Drug treatment of irritable bowel syndrome: an unmet need]. Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:3 Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine	2007

Article

Year

[Drug treatment of irritable bowel syndrome: an unmet need].

Gastroenterologia y hepatologia, 2007, Volume: 30, Issue:3

Topics: Abdominal Pain; Analgesics; Antidepressive Agents, Tricyclic; Antidiarrheals; Carbolines; Controlled Clinical Trials as Topic; Diarrhea; Dicyclomine; Gastrointestinal Agents; Humans; Irritable Bowel Syndrome; Life Style; Loperamide; Meta-Analysis as Topic; Morpholines; Muscarinic Antagonists; Odds Ratio; Parasympatholytics; Phenethylamines; Quality of Life; Risk; Scopolamine; Scopolamine Derivatives; Serotonin Antagonists; Serotonin Receptor Agonists; Surveys and Questionnaires; Time Factors; Treatment Outcome; Trimebutine

2007

Other Studies

2 other study(ies) available for trimebutine and scopolamine hydrobromide

Article	Year
Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification. Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12 Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship	2012
Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog. International journal of clinical pharmacology, therapy, and toxicology, 1984, Volume: 22, Issue:7 Topics: Acetylcholine; Animals; Colon; Dogs; Female; Gastrointestinal Motility; Male; Parasympatholytics; Pyrrolidines; Scopolamine; Trimebutine	1984

Article

Year

Mitigating the inhibition of human bile salt export pump by drugs: opportunities provided by physicochemical property modulation, in silico modeling, and structural modification.

Drug metabolism and disposition: the biological fate of chemicals, 2012, Volume: 40, Issue:12

Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Bile Acids and Salts; Cell Line; Chemical and Drug Induced Liver Injury; Humans; Quantitative Structure-Activity Relationship

2012

Effect of antispasmodic drugs on colonic motility. Part I: Laboratory study of the dog.

International journal of clinical pharmacology, therapy, and toxicology, 1984, Volume: 22, Issue:7

Topics: Acetylcholine; Animals; Colon; Dogs; Female; Gastrointestinal Motility; Male; Parasympatholytics; Pyrrolidines; Scopolamine; Trimebutine

1984